RHZE

DRUG2 trials

Sponsors

Sequella, Inc., David Boulware

Conditions

HIV/AIDS TuberculosisTuberculosis

Phase 2

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

CompletedNCT01225640

Sequella, Inc.Tuberculosis

Start: 2011-08-31End: 2011-12-31Updated: 2016-01-14

A Phase 2 Novel Antimicrobial Combination Therapy to Treat Tuberculous Meningitis

Active, not recruitingPACTR202503871271189

David BoulwareHIV/AIDS Tuberculosis

Start: 2025-12-01Target: 150Updated: 2026-08-03

Related Papers

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

PLoS ONE2014-04-14161 citations